About BioAutomation
BioAutomation is a company based in Irving (United States) founded in 1999 was acquired by LGC in May 2018.. The company has 14 employees as of December 31, 2017. BioAutomation offers products and services including MerMade Synthesizers, Oligo Synthesis Reagents, and NGS Kits and Workflows. BioAutomation operates in a competitive market with competitors including Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, Mesa Biotech and DNA Script, among others.
- Headquarter Irving, United States
- Employees 14 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioautomation Corp
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAutomation
BioAutomation offers a comprehensive portfolio of products and services, including MerMade Synthesizers, Oligo Synthesis Reagents, and NGS Kits and Workflows. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated tools for oligonucleotide synthesis in research.
Materials for custom DNA and RNA production.
Kits for next-generation sequencing applications.
Funding Insights of BioAutomation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioAutomation
BioAutomation has secured backing from 1 investor. Prominent investors backing the company include LGC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular biology reagents and services are supplied to biotech industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioAutomation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioAutomation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioautomation Comparisons
Competitors of BioAutomation
BioAutomation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, Mesa Biotech and DNA Script, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostic kits are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Benchtop DNA printers for nucleic acid synthesis are developed.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics are developed via proprietary biochip platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioAutomation
When was BioAutomation founded?
BioAutomation was founded in 1999.
Where is BioAutomation located?
BioAutomation is headquartered in Irving, United States. It is registered at Irving, Texas, United States.
How many employees does BioAutomation have?
As of Dec 31, 2017, the latest employee count at BioAutomation is 14.
What does BioAutomation do?
BioAutomation was founded in 1999 in Irving, United States, within the biotechnology sector. Oligonucleotide synthesizers and reagents are developed, with the MerMade system utilized for column-based synthesis of DNA, RNA, and LNA oligonucleotides using standard or modified chemistries. Synthesis reagents for MerMade are created in partnership with Hongene Biotech, Link Technologies, EMD, and Biosearch Technologies. Operations focus on equipment and chemical solutions for molecular biology applications.
Who are the top competitors of BioAutomation?
BioAutomation's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.
What products or services does BioAutomation offer?
BioAutomation offers MerMade Synthesizers, Oligo Synthesis Reagents, and NGS Kits and Workflows.
Who are BioAutomation's investors?
BioAutomation has 1 investor. Key investors include LGC.